PRIMARY STUDY
The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management
Key Findings: This review finds that tetrahydrocannabivarin (THCV) has unique pharmacological properties that make it appealing for the development of novel therapeutics to address obesity and diabetes.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): South Korea
Year of Pub: 2025
Cannabinoids Studied: Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1 antagonist, CB2 agonist
Citation: Mendoza S. The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management. AIMS Neurosci. 2025 Mar 12;12(1):32-43. doi: 10.3934/Neuroscience.2025003. PMID: 40270953; PMCID: PMC12011981.
